SCHEMBL4778102

SCHEMBL4778102

CCn1cnc2c(=O)nc(Cc3ccccc3Cl)n(-c3ccc(F)cc3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CNR1 P21554 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
USP7 Q93009 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HKDC1 Q2TB90 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
TP53 P04637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772467 0.85 MAT2A (0.40) CNR1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4531050 0.85 SMN1; SMN2 (0.42) MAPK1NPSR1HSD17B10CNR1ALDH1A1
SCHEMBL4768907 0.83 SMN1; SMN2 (0.34) HSD17B10ALDH1A1KDM4ESMN1; SMN2HKDC1
SCHEMBL4357095 0.80 MAT2A (0.38) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL4776782 0.80 CDK1 (0.33) HSD17B10SMN1; SMN2HKDC1PDE4APDE4B
SCHEMBL4522632 0.77 HKDC1 (0.39) MAPK1CNR1ALDH1A1KDM4EUSP7
SCHEMBL4774078 0.77 MEN1 (0.38) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL4518958 0.76 SMN1; SMN2 (0.43) MAPK1HSD17B10ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4532511 0.76 CNR1 (0.45) NPSR1HSD17B10CNR1ALDH1A1SMN1; SMN2
SCHEMBL4772408 0.75 TRPV4 (0.33) MAPK1ALDH1A1SMN1; SMN2HKDC1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed